Kiora Pharmaceuticals (KPRX) Tax Provisions (2024 - 2025)
Kiora Pharmaceuticals' (KPRX) quarterly Tax Provisions came in at -$667821.0 in Q4 2025, down 132.34% YoY from $2.1 million in Q4 2024, and down 3.84% on a QoQ basis from -$643129.0 in Q3 2025.
Kiora Pharmaceuticals (KPRX) Tax Provisions (2024 - 2025) Analysis & Trends
Kiora Pharmaceuticals (KPRX) has 2 years of Tax Provisions data on file, last reported at -$667821.0 in Q4 2025.
- Quarterly Tax Provisions fell 132.34% year-over-year to -$667821.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$1.4 million (down 165.04% YoY) and the FY2025 annual result came in at -$1.3 million, down 162.95% from the prior year.
- Tax Provisions fell to -$667821.0 in Q4 2025, from -$643129.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $2.1 million in Q4 2024 to a low of -$667821.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.31 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.90 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -90.33 Mn |
| 10 | Kiora Pharmaceuticals | 16.25 Mn | 16.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -667,821.00 |
| Sep 30, 2025 | -643,129.00 |
| Jun 30, 2025 | -112,057.00 |
| Mar 31, 2025 | 123,006.00 |
| Dec 31, 2024 | 2.07 Mn |